Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Enzene Opens New Biomanufacturing Facility in Hopewell, NJ | Contract Pharma
Breaking News

Enzene Opens New Biomanufacturing Facility in Hopewell, NJ

The site leverages the company’s modular EnzeneX 2.0 platform, a fully connected continuous manufacturing technology.

Enzene, a global development and manufacturing organization based in India, has expanded its global biotech capabilities in the U.S. with the opening of a state-of-the-art biomanufacturing facility in Hopewell, NJ. The new 80,000-sq.-ft. facility represents Enzene’s first major manufacturing investment in the U.S. to support pharmaceutical innovation and supply chain resilience across North America. 

In addition to fed-batch drug substance manufacturing, the site leverages the company’s modular EnzeneX 2.0 platform, a fully connected continuous manufacturing (FCCM) technology. The platform is scalable and leverages optimized cell media and process analytical technology (PAT) to achieve 10-times the yield of conventional biomanufacturing, reducing the cost of goods sold to as low as $40 per gram.

“We are proud to bring our global expertise to the U.S. and contribute to the advancement of biopharmaceutical manufacturing,” added Himanshu Gadgil, Ph.D., CEO of Enzene. “Our first-to-market manufacturing technology is forging a new path in biologics manufacturing that will provide a cost-efficient, high yield, U.S.-based biomanufacturing solution for biopharmaceutical innovators, and complement our facilities in India to provide global supply solutions.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters